Literature DB >> 25006125

Resolution of acute inflammation bridges the gap between innate and adaptive immunity.

Justine Newson1, Melanie Stables1, Efthimia Karra1, Frederick Arce-Vargas2, Sergio Quezada2, Madhur Motwani1, Matthias Mack3, Simon Yona1, Tatsiana Audzevich1, Derek W Gilroy1.   

Abstract

Acute inflammation is traditionally characterized by polymorphonuclear leukocytes (PMN) influx followed by phagocytosing macrophage (Mφs) that clear injurious stimuli leading to resolution and tissue homeostasis. However, using the peritoneal cavity, we found that although innate immune-mediated responses to low-dose zymosan or bacteria resolve within days, these stimuli, but not hyperinflammatory stimuli, trigger a previously overlooked second wave of leukocyte influx into tissues that persists for weeks. These cells comprise distinct populations of tissue-resident Mφs (resMφs), Ly6c(hi) monocyte-derived Mφs (moMφs), monocyte-derived dendritic cells (moDCs), and myeloid-derived suppressor cells (MDSCs). Postresolution mononuclear phagocytes were observed alongside lymph node expansion and increased numbers of blood and peritoneal memory T and B lymphocytes. The resMφs and moMφs triggered FoxP3 expression within CD4 cells, whereas moDCs drive T-cell proliferation. The resMφs preferentially clear apoptotic PMNs and migrate to lymph nodes to bring about their contraction in an inducible nitric oxide synthase-dependent manner. Finally, moMφs remain in tissues for months postresolution, alongside altered numbers of T cells collectively dictating the magnitude of subsequent acute inflammatory reactions. These data challenge the prevailing idea that resolution leads back to homeostasis and asserts that resolution acts as a bridge between innate and adaptive immunity, as well as tissue reprogramming.
© 2014 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25006125      PMCID: PMC4383794          DOI: 10.1182/blood-2014-03-562710

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  48 in total

Review 1.  Resolution of inflammation: the beginning programs the end.

Authors:  Charles N Serhan; John Savill
Journal:  Nat Immunol       Date:  2005-12       Impact factor: 25.606

2.  Unresponsiveness to experimental allergic encephalomyelitis in Lewis rats pretreated with complete Freund's adjuvant.

Authors:  K Hempel; A Freitag; B Freitag; B Endres; B Mai; G Liebaldt
Journal:  Int Arch Allergy Appl Immunol       Date:  1985

3.  Passive transfer of experimental allergic encephalomyelitis: mechanisms of suppression.

Authors:  G A Falk; M W Kies; E C Alvord
Journal:  J Immunol       Date:  1969-12       Impact factor: 5.422

4.  Dynamic interplay among monocyte-derived, dermal, and resident lymph node dendritic cells during the generation of vaccine immunity to fungi.

Authors:  Karen Ersland; Marcel Wüthrich; Bruce S Klein
Journal:  Cell Host Microbe       Date:  2010-06-25       Impact factor: 21.023

Review 5.  Immunomodulatory functions of type I interferons.

Authors:  José M González-Navajas; Jongdae Lee; Michael David; Eyal Raz
Journal:  Nat Rev Immunol       Date:  2012-01-06       Impact factor: 53.106

6.  Experimental allergic encephalomyelitis in Lewis rats: inhibition by bacterial lipopolysaccharides and acquired resistance to reinduction by challenge with myelin basic protein.

Authors:  S Raziuddin; R F Kibler; D C Morrison
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

7.  Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. Role of IFN-gamma in the induction of the nitric oxide-synthesizing pathway.

Authors:  J E Albina; J A Abate; W L Henry
Journal:  J Immunol       Date:  1991-07-01       Impact factor: 5.422

8.  Nitric oxide mediates immunosuppression induced by Listeria monocytogenes infection: quantitative studies.

Authors:  A S MacFarlane; D Huang; M G Schwacha; J J Meissler; J P Gaughan; T K Eisenstein
Journal:  Microb Pathog       Date:  1998-11       Impact factor: 3.738

9.  Macrophages regulate induction of delayed-type hypersensitivity and experimental allergic encephalomyelitis in SJL mice.

Authors:  D J Cua; D R Hinton; L Kirkman; S A Stohlman
Journal:  Eur J Immunol       Date:  1995-08       Impact factor: 5.532

10.  Transcriptomic analyses of murine resolution-phase macrophages.

Authors:  Melanie J Stables; Sonia Shah; Evelyn B Camon; Ruth C Lovering; Justine Newson; Jonas Bystrom; Stuart Farrow; Derek W Gilroy
Journal:  Blood       Date:  2011-10-19       Impact factor: 22.113

View more
  68 in total

1.  Cellular dynamics of resolving inflammation.

Authors:  Juhi Bagaitkar
Journal:  Blood       Date:  2014-09-11       Impact factor: 22.113

2.  Therapeutic tissue regeneration by a macrophage colony-stimulating factor Fc conjugate.

Authors:  Jasper G van den Boorn; Gunther Hartmann
Journal:  Mol Ther       Date:  2014-09       Impact factor: 11.454

3.  Macrophage Metabolism of Apoptotic Cell-Derived Arginine Promotes Continual Efferocytosis and Resolution of Injury.

Authors:  Arif Yurdagul; Manikandan Subramanian; Xiaobo Wang; Scott B Crown; Olga R Ilkayeva; Lancia Darville; Gopi K Kolluru; Christina C Rymond; Brennan D Gerlach; Ze Zheng; George Kuriakose; Christopher G Kevil; John M Koomen; John L Cleveland; Deborah M Muoio; Ira Tabas
Journal:  Cell Metab       Date:  2020-01-30       Impact factor: 27.287

Review 4.  Resolution of inflammation: a new therapeutic frontier.

Authors:  James N Fullerton; Derek W Gilroy
Journal:  Nat Rev Drug Discov       Date:  2016-03-29       Impact factor: 84.694

5.  Progress does not just come in giant leaps: adapting techniques for the study of inflammation to novel applications.

Authors:  Michael J Parnham
Journal:  Inflamm Res       Date:  2016-09-28       Impact factor: 4.575

6.  Blocking elevated p38 MAPK restores efferocytosis and inflammatory resolution in the elderly.

Authors:  Roel P H De Maeyer; Rachel C van de Merwe; Rikah Louie; Olivia V Bracken; Oliver P Devine; Daniel R Goldstein; Mohib Uddin; Arne N Akbar; Derek W Gilroy
Journal:  Nat Immunol       Date:  2020-04-06       Impact factor: 25.606

7.  Plasmin and plasminogen induce macrophage reprogramming and regulate key steps of inflammation resolution via annexin A1.

Authors:  Michelle A Sugimoto; Ana Luíza C Ribeiro; Bruno R C Costa; Juliana P Vago; Kátia M Lima; Fernanda S Carneiro; Mylena Maira O Ortiz; Graziele Letícia N Lima; Aline A F Carmo; Renata M Rocha; Denise A Perez; Alessandra C Reis; Vanessa Pinho; Lindsey A Miles; Cristiana C Garcia; Mauro M Teixeira; Lirlândia P Sousa
Journal:  Blood       Date:  2017-03-20       Impact factor: 22.113

8.  CRIg-expressing peritoneal macrophages are associated with disease severity in patients with cirrhosis and ascites.

Authors:  Katharine M Irvine; Xuan Banh; Victoria L Gadd; Kyle K Wojcik; Juliana K Ariffin; Sara Jose; Samuel Lukowski; Gregory J Baillie; Matthew J Sweet; Elizabeth E Powell
Journal:  JCI Insight       Date:  2016-06-02

Review 9.  The Dynamics of Apoptotic Cell Clearance.

Authors:  Michael R Elliott; Kodi S Ravichandran
Journal:  Dev Cell       Date:  2016-07-25       Impact factor: 12.270

10.  D-series Resolvins activate Phospholipase D in phagocytes during inflammation and resolution.

Authors:  Ramya Ganesan; Karen M Henkels; Krushangi Shah; Xavier De La Rosa; Stephania Libreros; Nagarjuna R Cheemarla; Charles N Serhan; Julian Gomez-Cambronero
Journal:  FASEB J       Date:  2020-10-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.